09 Jul 2020 --- As the potential benefits of human milk oligosaccharides (HMOs) continue to be elucidated for infants and adults alike, DuPont Nutrition & Biosciences (N&B) is making major steps in its HMO sector. A new Finnish study has revealed that dental caries-associated bacterium Streptococcus mutans is unable to grow on the company’s Care4U 2’-Fucosyllactose (2’-FL), in contrast to on galacto-oligosaccharides (GOS) and lactose. Meanwhile, a scientific expert panel recently concluded that the Care4U 3-FL, which the company is planning to commercialize, is Generally Recognized as Safe (GRAS) for a range of uses, including foods for consumers of all ages.
